Javascript must be enabled to continue!
Pharmacotherapy of Hypoactive Sexual Desire
View through CrossRef
The article reports that hypoactive sexual desire occurs quite often in both sexes, but in women, such a complaint came to the first position. The article is devoted to the presentation and discussion of various medications and dietary supplements used to enhance sexual desire in women and men. Adaptogens is reported to enhance libido. Flibanserin was the first drug approved in the United States by the Food and Drug Administration (FDA) for the treatment of acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Testosterone is used in men and women with a weakened libido, and Tibolone enhances sexual desire in women.
Also reported on the use of bremelanotide, the second drug approved by the FDA for the treatment of acquired generalized HSDD in premenopausal women, which is also used to increase sexual desire in men. It is informed that it also increases libido in men. In addition, bupropion and its combination with trazadone have been reported to enhance libido in women. Buspirone is reportedly used to treat sexual side effects, including diminished libido, caused by antidepressants from the selective serotonin reuptake inhibitor group.
It has been noted that the enhancing sex drive in men and women may cause Tribulus Terrestris L. use and drugs created on its basis (Tribestan and its analogues). To enhance the sexual desire, two combined drugs are tested: testosterone + sildenafil and testosterone + buspirone. Also named a number of biologically active supplements used to strengthen the weakened libido and eliminate other sexual dysfunctions.
Title: Pharmacotherapy of Hypoactive Sexual Desire
Description:
The article reports that hypoactive sexual desire occurs quite often in both sexes, but in women, such a complaint came to the first position.
The article is devoted to the presentation and discussion of various medications and dietary supplements used to enhance sexual desire in women and men.
Adaptogens is reported to enhance libido.
Flibanserin was the first drug approved in the United States by the Food and Drug Administration (FDA) for the treatment of acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Testosterone is used in men and women with a weakened libido, and Tibolone enhances sexual desire in women.
Also reported on the use of bremelanotide, the second drug approved by the FDA for the treatment of acquired generalized HSDD in premenopausal women, which is also used to increase sexual desire in men.
It is informed that it also increases libido in men.
In addition, bupropion and its combination with trazadone have been reported to enhance libido in women.
Buspirone is reportedly used to treat sexual side effects, including diminished libido, caused by antidepressants from the selective serotonin reuptake inhibitor group.
It has been noted that the enhancing sex drive in men and women may cause Tribulus Terrestris L.
use and drugs created on its basis (Tribestan and its analogues).
To enhance the sexual desire, two combined drugs are tested: testosterone + sildenafil and testosterone + buspirone.
Also named a number of biologically active supplements used to strengthen the weakened libido and eliminate other sexual dysfunctions.
Related Results
The Object of Sexual Desire: Examining the “What” in “What Do You Desire?”
The Object of Sexual Desire: Examining the “What” in “What Do You Desire?”
Abstract
Introduction
Over the past two decades, sexual desire and desire discrepancy have become more frequently studied as hav...
ORIGINAL RESEARCH—PSYCHOLOGY: Sexual Desire in Women: An Integrative Approach Regarding Psychological, Medical, and Relationship Dimensions
ORIGINAL RESEARCH—PSYCHOLOGY: Sexual Desire in Women: An Integrative Approach Regarding Psychological, Medical, and Relationship Dimensions
ABSTRACT
Introduction
Sexual desire depends on the balance between biologic, psychological, and cultural values. Therefore, conc...
277 Evaluation of the Sexual Desire Disorders in the Post-Partum Period
277 Evaluation of the Sexual Desire Disorders in the Post-Partum Period
ABSTRACT
Introduction
A woman's sexuality changes throughout her life and varies according to endogenous and exogenous factors. ...
Efficacy of Flibanserin in Women with Hypoactive Sexual Desire Disorder: Results from the BEGONIA Trial
Efficacy of Flibanserin in Women with Hypoactive Sexual Desire Disorder: Results from the BEGONIA Trial
ABSTRACT
Introduction
Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked d...
The Sexual Functioning Profile of a Nonforensic Sample of Individuals Reporting Sexual Aggression Against Women
The Sexual Functioning Profile of a Nonforensic Sample of Individuals Reporting Sexual Aggression Against Women
ABSTRACTIntroductionSexual offenders are believed to present marked sexual difficulties. However, most of the studies characterizing sex offenders' sexual functioning were conducte...
(184) The Prevalence of Sexual Dysfunction in Women Seeking Infertility Treatment in Vietnam
(184) The Prevalence of Sexual Dysfunction in Women Seeking Infertility Treatment in Vietnam
Abstract
Introduction
Sexual function plays a crucial role in women's psychosocial and overall well-being, significantly impacti...
Pathways of Sexual Desire
Pathways of Sexual Desire
ABSTRACTIntroductionSexual desire is controlled by brain systems involved in sexual excitation and inhibition. Hypoactive sexual desire disorder (HSDD) may result from hypofunction...
Girl Child Sexual Abuse in Lusaka Urban
Girl Child Sexual Abuse in Lusaka Urban
The study on girl child sexual abuse and whose findings are presented in this article was conducted in 2010 as an academic requirement for the purpose of completing a Master’s degr...

